Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors-Reference-Cited by-同舟云学术

Loss of CtIP disturbs homologous recombination repair and sensitizes breast cancer cells to PARP inhibitors

Published:2015-12-22 Issue:7 Volume:7 Page:7701-7714
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Junhui¹²,Ding Qianshan³,Fujimori Hiroaki¹⁴,Motegi Akira⁵,Miki Yoshio²,Masutani Mitsuko¹⁴

Affiliation:

1. Division of Chemotherapy and Clinical Cancer Research, National Cancer Center Research Institute, Tokyo 104-0045, Japan

2. Department of Molecular Genetics, Division of Medical Genomics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

3. Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan 430060, China

4. Department of Frontier Life Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan

5. Department of Radiation Genetics, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes;Expert Review of Anticancer Therapy;2024-09-03

2. Star wars against leukemia: attacking the clones;Leukemia;2024-09-02

3. A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome;Journal of Molecular Medicine;2023-08-24

4. Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance;EMBO Molecular Medicine;2023-01-18

5. Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status;Journal of Ovarian Research;2023-01-07